Regional Brain Measurement of Bmax and KD with the Opiate Antagonist Cyclofoxy: Equilibrium Studies in the Conscious Rat
Open Access
- 1 July 1991
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 11 (4) , 529-544
- https://doi.org/10.1038/jcbfm.1991.102
Abstract
Brain distribution of the opiate receptor antagonist, cyclofoxy (CF), was evaluated at equilibrium in rats. A combination of i.v. injection and constant i.v. infusion was used to administer CF over a wide dose range (2.4–450 nmol/rat). Kinetic simulations and experimental results showed that this administration schedule accomplishes “true” tissue-blood equilibrium of CF within 60 min. To estimate the receptor-ligand binding parameters, we assumed that the CF concentration at the receptor site is identical to that in plasma water at equilibrium, and can be calculated from measured blood data after corrections for radiolabeled metabolites and plasma protein binding. This assumption was supported by CSF and plasma water measurements at equilibrium. Regional KD, Bmax, and a nonspecific tissue binding equilibrium constant ( Keq) were estimated by fitting the tissue and plasma water concentrations to a single receptor model; the estimated values were 1.4–2.9 n M, 15–74 pmol/g of tissue, and 5.2–8.0, respectively. They are in good agreement with previous in vitro measurements (Rothman and McLean, 1988) as well as in vivo estimates from i.v. injection experiments (Sawada et al., 1990 c). The conventional method to estimate the receptor-ligand binding parameters using data from cerebellum to approximate nonspecific tissue binding was found to be unacceptable. Although cerebellum is a brain region with no opiate receptors in rats, small differences in nonspecific tissue binding in different brain regions resulted in significant overestimations of KD and Bmax with this method. Receptor-active and -inactive enantiomers [[18F](-)-CF and [3H](+)-CF)] were simultaneously administered to the same animal and the receptor-bound CF concentration could be accurately measured; this method was used to estimate 5max from a single study in a single animal and has potential for direct application in human studies using positron emission tomography.Keywords
This publication has 32 references indexed in Scilit:
- Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium AnalysisJournal of Cerebral Blood Flow & Metabolism, 1989
- Quantitation of Photochemically Induced Focal Cerebral Ischemia in the RatJournal of Cerebral Blood Flow & Metabolism, 1988
- Kinetic Modeling of Receptor‐Ligand Binding Applied to Positron Emission Tomographic Studies with Neuroleptic TracersJournal of Neurochemistry, 1987
- Quantification of Neuroreceptors in the Living Human Brain. I. Irreversible Binding of LigandsJournal of Cerebral Blood Flow & Metabolism, 1986
- Strategies for in vivo Measurement of Receptor Binding Using Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1986
- Quantification of Neuroreceptors in the Living Human Brain. II. Inhibition Studies of Receptor Density and AffinityJournal of Cerebral Blood Flow & Metabolism, 1986
- Radiosynthesis of [18F]3-acetylcyclofoxy: a high affinity opiate antagonistThe International Journal of Applied Radiation and Isotopes, 1985
- Probes for Narcotic Receptor Mediated Phonomena 11. Synthesis of 17-Methyl and 17-Cyclopropylmethyl-3,14-dihydroxy-4,5a-epoxy-6b-fluoromorphinans (Foxy and Cyclofoxy) as Models of Opioid Ligands Suitable for Position Emission Transaxial TomographyHETEROCYCLES, 1985
- S‐[18F]Acetylcyclofoxy: a useful probe for the visualization of opiate receptors in living animalsFEBS Letters, 1984
- Autoradiographic localization of the opiate receptor in rat brainLife Sciences, 1975